Colgate-Palmolive Company 1993 Annual Report (10-K) Summary
Business Context and Reporting Period
This Form 10-K covers the fiscal year ended December 31, 1993. Colgate-Palmolive Company is a global manufacturer and marketer of consumer products organized into two primary segments: Oral, Personal and Household Care and Specialty Marketing. The company operates in over 50 countries with 266 facilities worldwide. The 1993 reporting period was significantly impacted by the adoption of new accounting standards (SFAS 106, 112, and 109) effective January 1, 1993, which resulted in a one-time non-cash charge.
Key Financial Metrics
| Metric (in millions, except per share) | 1993 | 1992 |
|---|---|---|
| Net Sales | $7,141.3 | $7,007.2 |
| Gross Profit | $3,411.4 | $3,298.8 |
| Gross Margin | 47.8% | 47.1% |
| Net Income (Reported) | $189.9 ($1.08/share) | $477.0 ($2.92/share) |
| Net Income (Excl. Accounting Changes) | $548.1 ($3.38/share) | $477.0 ($2.92/share) |
| EBIT | $883.0 | $777.9 |
| Operating Cash Flow | $710.4 | $542.7 |
| Capital Expenditures | $364.3 | $318.5 |
| Long-Term Debt | $1,532.4 | $946.5 |
| Debt to Total Capitalization | 48% | 30% |
Material Changes vs. Prior Period
- Revenue Growth: Worldwide sales increased 2% to $7,141.3 million. Excluding unfavorable foreign currency translation, sales would have grown 7%. Volume increased 5%, driven by the consolidation of the Indian operation and strong performance in Asia/Africa and Latin America.
- Profitability: Gross profit margin improved to 47.8% due to a strategic shift toward higher-margin personal care products and manufacturing efficiencies. EBIT increased 14% to $883.0 million.
- Accounting Impact: Reported net income of $189.9 million includes a cumulative one-time charge of $358.2 million related to the adoption of new standards for income taxes and postretirement benefits. Excluding this charge, net income increased 15% to $548.1 million.
- Capital Structure: The debt-to-total-capitalization ratio rose to 48% from 30% in 1992. This shift was driven by significant share repurchases ($673.0 million) and increased debt issuance to finance these buybacks and acquisitions.
- Acquisitions: The company spent $222.5 million on acquisitions in 1993, including liquid hand/body soap brands from S.C. Johnson Wax and the Cristasol glass cleaner business.
Outlook, Risks, and Management Commentary
- Outlook: Management anticipates continued recessionary conditions in certain major markets for 1994 but expects strong growth opportunities in developing world markets. The global economic situation is not expected to differ materially from 1993.
- Capital Allocation: The company plans to maintain capital expenditures at approximately 5% of sales. Dividends were increased by 16% in 1993 to $1.34 per share. The Board authorized an additional repurchase of up to 5 million shares in early 1994.
- Risks and Contingencies:
- Currency: Significant exposure to foreign currency fluctuations, which negatively impacted reported sales and EBIT in Europe and Australia/New Zealand.
- Raw Materials: Prices for commodities like tallow and essential oils are subject to wide variations.
- Legal/Environmental: The company is a party to various Superfund and environmental matters, though management believes these will not have a material impact on financial condition.
Investor Verification Checklist
- Adjusted Earnings: Verify the $548.1 million "income before changes in accounting" figure to assess true operational performance, as the reported net income is distorted by the $358.2 million non-cash accounting charge.
- Currency Impact: Review the geographic breakdown to understand the divergence between volume growth (5%) and reported sales growth (2%) due to foreign exchange rates.
- Debt Levels: Confirm the sustainability of the increased leverage (48% debt ratio) given the aggressive share repurchase program and the company's ability to service $1.5 billion in long-term debt.
- Acquisition Integration: Monitor the integration and performance of the 1993 acquisitions (S.C. Johnson brands, Cristasol) and the newly consolidated Indian operation.
- Postretirement Obligations: Review Note 8 regarding the unfunded postretirement benefit obligation of $205.8 million and the sensitivity of this liability to medical cost trend rates.